Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | 860 dias atrás
Stocktwits
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

Marcadores : HOTH
Stocktwits
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 604 dias atrás
German Factory Orders Rebound Ahead Of U.S. Tariffs

German Factory Orders Rebound Ahead Of U.S. Tariffs

Germany's factory orders grew more than expected in March as U.S. manufacturers front-loaded their orders to avoid higher tariffs, official data revealed Wednesday. Factory orders advanced 3.6 percent month-on-month in March after remaining flat in February, Destatis reported. Orders are forecast to grow 1.4 percent.
RTTNews | 28 minutos atrás
Bay Street Likely To Open Higher

Bay Street Likely To Open Higher

Canadian shares may open higher on Wednesday amid renewed hopes the U.S. and China will agree on a positive trade deal. The focus is also on the Federal Reserve's monetary policy announcement later in the day.
RTTNews | 1h 35min atrás
FTSE Modestly Lower In Cautious Trade

FTSE Modestly Lower In Cautious Trade

The U.K. market is modestly lower on Wednesday as investors largely tread cautiously, digesting earnings and regional economic data, and awaiting the monetary policy announcements from the Federal Reserve and the Bank of England.
RTTNews | 3h 15min atrás
UK Construction Sector Continues To Shrink

UK Construction Sector Continues To Shrink

The UK construction activity continued to contract in April as business uncertainty and concerns about economic outlook damped client demand, survey data from S&P Global showed on Wednesday. The construction Purchasing Managers' Index rose unexpectedly to 46.6 in April from 46.4 in March. This was the slowest decline in output levels for three months.
RTTNews | 3h 18min atrás
CAC 40 Moderately Lower Ahead Of Fed Policy Announcement

CAC 40 Moderately Lower Ahead Of Fed Policy Announcement

French stocks are down in negative territory Wednesday morning with investors making cautious moves, reacting to earnings, and awaiting the Federal Reserve's monetary policy announcement, due later in the day.
RTTNews | 3h 42min atrás
Ferramentas
Calendário Econômico
Market Hours
Interest Rates
Holidays Calendar
Mercado Forex
Volatilidade no Forex
Correlação no Forex
Notícias sobre Forex
forex analysis
Dados do COT
Liquidez
Calculadoras Forex
Mapa do Calor do Forex
Indicators Heatmap
Comunidade
Comunidade
Sistemas
Sistemas Mais Populares
Estratégias
Concursos
Gráficos de Forex
Sentimento do Forex
Indicador de Perspectivas
Análises
Corretoras
Prop Trading Firms
Serviços de VPS
Provedores de Sinais
Serviços de Programação de EA
Affiliate Programs
Serviços de Corretora PAMM
Serviços de Programa de Reembolso
Plataformas de Trading
Expert Advisors
Exchanges de Criptomoedas
Trading Courses
Corretoras
Spreads das Corretoras de Forex
Cotações de Corretoras de Forex
Swaps de Corretoras de Forex
Volume da Corretora de Forex
Promoções de Corretoras de Forex Press Release
Plataforma
Widgets
Recursos
API
RSS
Stock Portfolio
Affiliate Software
Gráficos Avançados
Assistência
Perguntas Frequentes
Ajuda
Entre em contato conosco
Relatar um erro!
Sobre
Blog
© 2025 Myfxbook Ltd. Todos os Direitos Reservados.
AVISO DE ALTO RISCO: A negociação no mercado de câmbio traz consigo um alto nível de risco que pode não ser adequado para qualquer investidor. A alavancagem cria exposição adicional a riscos e perdas. Antes de decidir negociar no mercado de câmbio, considere cuidadosamente seus objetivos de investimento, seu nível de experiência e sua tolerância ao risco. Você pode perder parte de seu investimento inicial ou todo ele. Não invista um dinheiro que você não tem condições de perder. Informe-se sobre os riscos associados à negociação no mercado de câmbio e procure o conselho de um consultor financeiro ou fiscal independente, caso tenha alguma dúvida. Quaisquer dados e informações são fornecidos "como estão" exclusivamente para fins informativos. Eles não se destinam a fins comerciais ou de aconselhamento. O desempenho passado não é indicativo de resultados futuros.